Sign inJoin waitlistJoin the waitlist

AE

Arielle Elkrief

Co-Director CHUM Microbiome Centre · New York Presbyterian Hospital

Credentials: · ·

History

New York Presbyterian Hospital
Present
New York Presbyterian Hospital
Present

Medical Oncology
Internal Medicine

Research

Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
The Lancet · 2020 · 1,345 citations
Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancer
Nature Medicine · 2022 · 609 citations
Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial
Nature Medicine · 2023 · 440 citations

AS
Adam Schoenfeld
24 papers · 11 as a fellow
Biagio Ricciuti
20 papers · 20 as a resident
MA
Mark Awad
20 papers
ML
Marc Ladanyi
19 papers
AD
Antoine Desilets
14 papers
Charles Rudin
11 papers
Lynette Sholl
11 papers
BJ
Bruce Johnson
10 papers
MG
Malini Gandhi
10 papers · 7 as a resident
Scott Rodig
9 papers
GR
Gregory Riely
8 papers
VV
Victor Vaz
8 papers · 8 as a resident

Clinical trials

KAN-004 for Immune-Related Diarrhea or Colitis
Principal investigator · Recruiting · Phase 1
Centre hospitalier de l'Université de Montréal (CHUM)
2026–2030
Impact of PEG Bowel Preparation on Gut Microbiome Composition Recovery
Principal investigator · Recruiting · Phase 1
Centre hospitalier de l'Université de Montréal (CHUM)
2024–2026
Camu-Camu Prebiotic and Immune Checkpoint Inhibition in Patients With Non-small Cell Lung Cancer and Melanoma
Principal investigator · Completed · Phase 1
Centre hospitalier de l'Université de Montréal (CHUM)
2022–2025